Authors:A. Svetina, Željka Matašin, Alenka Tofant, and et al.
Haematological and biochemical analyses of blood were performed in carp (Cyprinus carpio L.) kept in small ponds. Caught and anaesthetised carp were clinically examined and blood samples were taken at regular intervals during the three years. In the first year of examinations, the haemoglobin and haematocrit values of carp fry significantly increased (P<0.01) from June to September. The intensive growth of carp in the summer period in the second year was accompanied by adequate erythropoiesis. During hibernation haematocrit and haemoglobin significantly decreased (P<0.05) and mean corpuscular haemoglobin concentration (MCHC) increased (P<0.01) in both scaly and mirror carp. MCHC increased also with the age and increasing body weight of the fish. Mirror carp had lower haematocrit and haemoglobin values than scaly carp (P<0.01). Comparative haematological analyses between carp of normal and poor body condition showed that moderate anaemia appeared in those with poor body condition. The results indicate that there is marked seasonal and age-dependent variation in the values of haematocrit and haemoglobin. Pond water quality investigations indicated good environmental conditions. A 50% increase (P<0.05) of glucose concentration was found from June to September in the blood plasma of carp in the third year, accompanied by an even more increased (80%; P<0.01) concentration of total lipids. At the same time, considerable changes of cholesterol and total protein concentrations were not observed. The results suggest that the investigated haematological and biochemical variables could be successfully utilised in monitoring the metabolic balance and health status of fish in intensive culture.
The prevalence of hepatitis C virus infection among patients on hemodialysis is about ten times higher than in the normal population. The infection can induce chronic glomerulonephritis, as an extrahepatic manifestation, which can lead to end-stage renal disease. However, in the majority of patients hepatitis C virus is acquired as a nosocomial infection during hemodialysis. Most of the infected patients have usually normal liver enzymes and need regular screening for hepatitis C antibody to detect the infection. Despite the normal liver enzymes, the liver disease may progress to cirrhosis. Some of the patients are on the renal transplantation waiting list. The immunosuppressive treatment after renal transplantation results in a significantly increased viral replication which might induce further progression of the liver disease. Interferon treatment given after transplantation can induce rejection and graft failure. Therefore the antiviral treatment should be administered during or before the hemodialysis period. Only limited data are available about the treatment of patients with impaired renal function. Alfa-interferon was used mostly in these patients. Due to its impaired renal clearance and higher serum concentration interferon seems to be more effective, but less tolerable in patients with end-stage renal disease than in other groups of patients. Ribavirin is also excreted exclusively by the kidney with anemia being even more pronounced in these patients, and as such is contraindicated in patients on hemodialysis. The pharmacokinetics of the pegylated interferon alfa-2a is very advantageous for patients with end-stage renal disease. The safety and efficacy of peginterferon alfa-2a is now being confirmed in many publications.
Authors:Khadiga G. Adham, Manal H. Farhood, Maha H. Daghestani, Nadia A. Aleisa, Ahlam A. Alkhalifa, Maha H. El Amin, Promy Virk, Mai A. Al-Obeid, and Eman M. H. Al-Humaidhi
One of the common causes of iron overload is excessive iron intake in cases of iron-poor anemia, where iron saccharate complex (ISC) is routinely used to optimize erythropoiesis. However, non-standardized ISC administration could entail the risk of iron overload. To induce iron overload, Wistar rats were intraperitoneally injected with subacute (0.2 mg kg−1) and subchronic (0.1 mg kg−1) overdoses of ISC for 2 and 4 weeks, respectively. Iron status was displayed by an increase in transferrin saturation (up to 332%) and serum and liver iron burden (up to 19.3 μmol L−1 and 13.2 μmol g−1 wet tissue, respectively) together with a drop in total and unsaturated iron binding capacities “TIBC, UIBC” as surrogate markers of transferrin activity. Iron-induced leukocytosis (up to 140%), along with the decline in serum transferrin markers (up to 43%), respectively, mark positive and negative acute phase reactions. Chemical stress was demonstrated by a significant rise (p > 0.05) in indices of the hemogram (erythrocytes, hemoglobin, hematocrit, leukocytes) and stress metabolites [corticosterone (CORT) and lactate]. Yet, potential causes of the unexpected decline in serum activities of ALT, AST and LDH (p > 0.05) might include decreased hepatocellular enzyme production and/or inhibition or reduction of the enzyme activities. The current findings highlight the toxic role of elevated serum and liver iron in initiating erythropoiesis and acute phase reactions, modifying iron status and animal organ function, changing energy metabolism and bringing about accelerated glycolysis and impaired lactate clearance supposedly by decreasing anaerobic threshold and causing premature entering to the anaerobic system.
Authors:Fumina Sasaoka, Jin Suzuki, Toh-Ichi Hirata, Toshihiro Ichijo, Kazuhisa Furuhama, Ryô Harasawa, and Hiroshi Satoh
. , Griot , C. , Stark , K. D. C. , Willi , B. , Schmidt , J. , Kocan , K. M. and Lutz , H. ( 2004 ): Concurrent infections with vector-borne pathogens associated with fetal hemolytic anemia in a cattle herd in Switzerland . J. Clin. Microbiol
Sulkowski, M. S., Poordad, F., Manns, M. P., et al.: Anemia during treatment with peginterferon alfa-2b/ribavirin with or without boceprevir is associated with higher SVR rates: analysis of previously untreated and previous treatment – failure patients. J